At a glance
- Originator Merck & Co
- Class Antihypertensives
- Mechanism of Action Endothelin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gastrointestinal disorders; Heart failure; Hypertension; Inflammation; Renal failure; Subarachnoid haemorrhage
Most Recent Events
- 09 Feb 2000 No-Development-Reported for Congestive heart failure in USA (PO)
- 09 Feb 2000 No-Development-Reported for Gastrointestinal disorders in USA (PO)
- 09 Feb 2000 No-Development-Reported for Hypertension in USA (PO)